January 17, 2025

Risks of Preterm Birth, Low Birth Weight, Birth Defects Among Children Born to Young Men With Cancer

Investigators have explored the risk of having children who experience preterm birth, low birth weight, and birth defects among male adolescents and young adults with cancer.

The ASCO Post

January 17, 2025

AACR Expresses Sincere Appreciation After NIH Director Monica M. Bertagnolli, MD, Steps Down

The American Association for Cancer Research (AACR) expressed its gratitude to Monica M. Bertagnolli, MD, for her outstanding service to the United States during her 14-month tenure as Director of the...

The ASCO Post

January 16, 2025

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE Trial

Adjuvant treatment with an antibody-drug conjugate (ADC) may improve survival in patients with high-risk HER2-positive breast cancer and residual invasive disease.

The ASCO Post

January 16, 2025

Exercise Therapy as Candidate Anticancer Strategy

Lee Jones, PhD, Head of the Exercise Oncology Program at Memorial Sloan Kettering Cancer Center, shared findings from an early-phase clinical trial to determine the feasibility, safety, and tumor biol...

The ASCO Post

January 16, 2025

MRI and Biopsy May Reduce Treatment Delays for Muscle-Invasive Urothelial Carcinoma

Multiparametric MRI and biopsy may speed up the time to correct treatment among patients with muscle-invasive urothelial carcinoma, according to recently published findings from the BladderPath trial.

The ASCO Post

January 16, 2025

Trastuzumab/Pertuzumab vs Cetuximab/Irinotecan in RAS/BRAF Wild-Type HER2-Positive Metastatic Colorectal Cancer

In a phase II trial (S1613) reported in Journal of Clinical Oncology, Raghav et al found no difference in progression-free survival overall with trastuzumab/pertuzumab vs cetuximab/irinotecan in secon...

The ASCO Post

January 15, 2025

Transplant-Free Treatment Approach in Relapsed Classical Hodgkin Lymphoma in Children and Adolescents and Young Adults

As reported in JAMA Oncology, Daw et al shared findings in a cohort of the phase II CheckMate 744 trial using a response-adapted transplantation-free treatment approach in children and adolescents and...

The ASCO Post

January 15, 2025

PFAS Contamination in Drinking Water May Be Linked to Several Rare Cancers

Investigators have explored a potential association between manufactured per- and polyfluoroalkyl substances (PFAS) levels in drinking water and the incidence of certain digestive, endocrine, lung, or...

The ASCO Post

January 15, 2025

Monica Bertagnolli, MD, FACS, FASCO, Steps Down as NIH Director

On January 14, Monica Bertagnolli, MD, FACS, FASCO, announced that she was ending her tenure as the 17th Director of the National Institutes of Health (NIH). She began her role as Director on November...

The ASCO Post